Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus

This study has been completed.
Sponsor:
Collaborators:
Northwestern University
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Julio C. Voltarelli, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT00315133
First received: April 13, 2006
Last updated: January 13, 2017
Last verified: January 2017